© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Teva Pharmaceuticals

HIV Drugmakers Gilead and Teva Didn’t Pay to Delay Drugs, Rules Jury

The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.
Megen Vo, MD, and Geoff Hart-Cooper, MD

PrEP Work

An HIV prevention roundup

44 States Sue 20 Makers of Generic Drugs Over Alleged Price Fixing

At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.

Generic PrEP to Arrive in September 2020, but Will Big Savings Follow?

Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.

Unraveling the Mysteries of U.S. Drug Pricing

Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?

FDA Approves Truvada-Like HIV Tablet Temixys

The tablet from the South Korean company Celltrion contains tenofovir disoproxil fumarate and lamivudine.

Teva Launches Generic Version of HIV Medication Reyataz

This marks the manufacturer’s fifth generic antiretroviral launch.
Advertisement

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.